Testimonial: OptionCare Health – Streamlining USP compliance across its facilities

In accordance with the March 2020 decision by USP to remand the 2019 revisions of General Chapters Pharmaceutical Compounding – Nonsterile Preparations and Pharmaceutical Compounding – Sterile Preparations, the USP is committed to gathering stakeholder feedback and proceeding in a transparent manner as the expert committees evaluate the course of action.

Here, we will review the impact pharmacy teams can make, focusing on key clinical focus areas that produce the greatest amount of return and/or cost savings for most facilities.

Dr. Steven Riddle reviews key elements of an effective opioid stewardship program and identifies challenges that have slowed adoption of these practices. Steve shares AI-powered tools developed by Wolters Kluwer - in collaboration with our customers - that empower pharmacists and other clinicians to enhance stewardship advances in their practice settings.

As one of the most expensive medical conditions in the country, the financial cost to U.S. health care for sepsis is estimated at a staggering 33 billion dollars per year and rising and sepsis remains the leading cause of hospital mortality